Arq, Inc. Earnings Call Transcripts
Fiscal Year 2026
-
Q2 2026 saw strong PAC business performance with higher margins and EBITDA, despite seasonal softness and a plant turnaround. The company reaffirmed 2026 guidance, advanced its PAC for PFAS initiative, and continues to review GAC investment while focusing on operational efficiency and cost reduction.
-
The meeting covered board elections, executive compensation, auditor ratification, and key incentive and tax protection plans, all of which were approved by majority vote. No questions were raised by stakeholders during the session.
-
Q1 2026 saw 7% revenue growth and strong PAC margins, despite non-cash and GAC-related costs. Full-year guidance is reiterated, with strategic GAC review and alternative PAC applications progressing. Board and management increased ownership, aligning with shareholders.
Fiscal Year 2025
-
GAC production is paused for a comprehensive review, with no output expected in 2026, while the PAC business continues to deliver strong growth, profitability, and high contract visibility. 2026 guidance projects $120–125M revenue and $17–20M adjusted EBITDA, all from PAC and other chemicals.
-
PAC business delivered strong results with higher prices and lower costs, while GAC achieved first commercial sales but faced production delays and high ramp-up costs. Full GAC capacity is now targeted for mid-2026, with strong market demand and ongoing product diversification efforts.
-
Revenue grew 13% year-over-year to $29M, with gross margin at 33% and adjusted EBITDA up 3x. The first GAC line was commissioned, initial sales made, and a second line decision is targeted by year-end. PAC business remains strong, with all contracts profitable in 2025.
-
Q1 2025 saw 25% revenue growth, strong margins, and a return to profitability, with PAC business now cash-generative and GAC commissioning delayed but progressing. Market conditions remain favorable, and new initiatives in asphalt and rare earths are advancing.
Fiscal Year 2024
-
2024 marked a successful turnaround with 10% revenue growth, margin expansion, and a strong PAC foundation. GAC production is ramping up, with robust demand and higher-margin opportunities ahead. Cost controls, new financing, and market dynamics position the company for continued growth.
-
Q3 2024 saw record revenue and margin improvements, driven by PAC business turnaround and strong GAC contract progress. Red River GAC facility is on track for Q1 2025, with potential capacity upside and robust demand across diversified markets.
-
Revenue rose 24% year-over-year with gross margin up to 32% and positive adjusted EBITDA. GAC contracts now cover 52% of capacity, and Red River commissioning remains on track for Q4 2024 with first deliveries in Q1 2025. Cash and capital position are strong.